Publications by authors named "Soichiro Tsukamoto"
Article Synopsis
- - The study analyzed the impact of immunotherapy on 67 patients with unresectable stage IVB gastric cancer treated at Yarita Hospital, comparing outcomes from an early group (2016-2017) and a late group (2018-2022).
- - Nivolumab was administered to 30% of patients, with a median overall survival of 11 months, showing longer survival in the early group compared to the late group (13 vs. 8.5 months). Transition rates to third-line treatments also increased from 22% to 33% over the study period.
- - The findings suggest that the introduction of new therapies has improved treatment options for patients with advanced gastric cancer, indicating a trend towards better management
We present the case of a 55-year-old man with HER2-positive, AFP-producing gastric cancer and multiple liver metastases. The patient consequently underwent 7 courses of SOX plus trastuzumab therapy, 3 courses of weekly PTX plus ramucirumab therapy, and 3 courses of nivolumab therapy, all of which resulted in PD. Obstruction due to tumor growth became noticeable 9 months after the start of the first treatment.
View Article and Find Full Text PDFBackground: Esophagostomy is important in the treatment of esophageal cancer. However, esophagectomy has a higher risk of postoperative complications. Treatment for complications is often difficult, and in some cases, oral intake is no longer possible.
View Article and Find Full Text PDFLymphedema of the arm and hand is one of the major complications after a breast cancer resection. Conservative treatment for the treatment of lymphedema, such as compression garments and centripetal massage, is very important for these cases. However, if the lymphedema is difficult to control with conservative treatment and the patient's quality of life (QOL) is compromised due to swelling of the arms, surgical treatment should be considered.
View Article and Find Full Text PDF